The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device. —
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Scope of the Report:
The global average price of Self-Injection Device is in the increasing trend, from 14.4 USD/Unit in 2012 to 15.2 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
Self-Injection Device is widely used for insulin injection, epinephrine injection and other field. The most proportion of Self Injection Device is used for insulin injection, and the proportion in 2016 is 86.5%. The trend of self-injection devices used for insulin injection is decreasing.
Europe is the largest consumption place, with a consumption market share nearly 42% in 2016. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
The worldwide market for Self Injection Device is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 9950 million US$ in 2024, from 7090 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Self Injection Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3735293-global-self-injection-device-market-2019-by-manufacturers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Reusable Self Injection Device
Disposable Self Injection Device
Market Segment by Applications, can be divided into
Insulin Injection
Epinephrine Injection
Other
Complete Report Details @ https://www.wiseguyreports.com/reports/3735293-global-self-injection-device-market-2019-by-manufacturers
Table Of Contents:
1 Market Overview
1.1 Self Injection Device Introduction
1.2 Market Analysis by Type
1.2.1 Reusable Self Injection Device
1.2.2 Disposable Self Injection Device
1.3 Market Analysis by Applications
1.3.1 Insulin Injection
1.3.2 Epinephrine Injection
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Self Injection Device Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novo Nordisk Self Injection Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Self Injection Device Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mylan Self Injection Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Self Injection Device Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Self Injection Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Self Injection Device Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Self Injection Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 BD
2.5.1 Business Overview
2.5.2 Self Injection Device Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BD Self Injection Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Self Injection Device Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Self Injection Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Gerresheimer
2.7.1 Business Overview
2.7.2 Self Injection Device Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Gerresheimer Self Injection Device Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Continued…….
Contact Info:
Name: Norah Trent
Email: Send Email
Organization: Wiseguyreports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com
Release ID: 482845